Trademark: 78649944
Word
EXAFAL
Status
Dead
Status Code
606
Status Date
Monday, June 29, 2009
Serial Number
78649944
Mark Type
4000
Filing Date
Tuesday, June 14, 2005
Published for Opposition
Tuesday, March 7, 2006
Abandoned Date
Monday, June 29, 2009

Trademark Owner History
Novartis AG - Owner At Publication

Classifications
5 Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, pharmaceutical preparations treating bacteria-based diseases, antivirals, anti-biotics, anti-fungals

Trademark Events
Jun 27, 2009
Teas Change Of Correspondence Received
Jun 29, 2009
Abandonment Notice Mailed - No Use Statement Filed
Jun 27, 2009
Teas Change Of Correspondence Received
Jun 29, 2009
Abandonment - No Use Statement Filed
Nov 24, 2008
Extension 5 Granted
Nov 24, 2008
Extension 5 Filed
Nov 24, 2008
Teas Extension Received
May 5, 2008
Extension 4 Granted
May 5, 2008
Extension 4 Filed
May 5, 2008
Teas Extension Received
Nov 19, 2007
Extension 3 Granted
Nov 19, 2007
Extension 3 Filed
Nov 19, 2007
Teas Extension Received
May 10, 2007
Extension 2 Granted
May 10, 2007
Extension 2 Filed
May 10, 2007
Teas Extension Received
Nov 7, 2006
Extension 1 Granted
Nov 7, 2006
Extension 1 Filed
Nov 7, 2006
Teas Extension Received
May 30, 2006
Noa Mailed - Sou Required From Applicant
Mar 7, 2006
Published For Opposition
Feb 15, 2006
Notice Of Publication
Jan 26, 2006
Law Office Publication Review Completed
Jan 20, 2006
Assigned To Lie
Jan 5, 2006
Approved For Pub - Principal Register
Jan 4, 2006
Assigned To Examiner
Nov 16, 2005
Teas Change Of Correspondence Received
Jun 20, 2005
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24